Summary
Machine-generated summaryThis request for offers covers two parts. Part 1 is the provision of whole genome sequencing (WGS) services. Part 2 is the provision of next generation sequencing (NGS) transcriptomic RNA-seq services. Both parts relate to the project 'DRUG-PREDICT', which aims to develop a technology for preclinical prediction of the clinical efficacy of biologically active compounds in colorectal and pancreatic cancer indications, based on a translational model. Both services are classified under research services (CPV 73110000-6) and are to be performed in Krakow, in the Malopolska region of Poland.
Description
Official source
Source: Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej)
Always verify details on the official notice.
Last verified against Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) 2 hours ago
More from this buyer
Full buyer profile11 open tenders right now
- Request for quotations SLV 15 09 2026 A 2 days left
- Request for offers SLV 24 08 2026 W 3 days left
- Request for quotation SLV 16 09 2026 A 5 days left
This buyer has no award history in this sector yet. Usual winners, Research & development - Poland
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| EVALU Sp. z o.o. | 5 | €87,037 | Aug 2026 |
| IBC Advisory S.A. | 4 | €120,798 | Jul 2026 |
| STREFA PRZYRODY Kamil Martyniak | 4 | €38,696 | Jun 2026 |
| Pracownia Badań i Analiz Przyrodniczych Dariusz Płąchocki | 3 | €57,396 | May 2026 |
| Openfield Sp. z o.o. | 3 | €38,980 | Aug 2026 |
Based on 204 awards with a linked company profile over the last 2 years.
Similar tenders
Market context
- Avg. open tender · Research & development
- €3,373,169
- Buyer track record on Aperlena
- 15 notices tracked · 0 awarded
Never miss a tender like this
115 new notices in Research & development in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alert